Caption Management, LLC Abb Vie Inc. Call Options Transaction History

Caption Management, LLC

$5.74 Billion
Q3 2024

Call Options

15 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $8.79 Million - $10 Million	-55,000 Reduced 52.38%	50,000 $9.11 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $6.88 Million - $7.75 Million	50,000 Added 90.91%	105,000 $16.3 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $1.99 Million - $2.47 Million	15,000 Added 37.5%	55,000 $7.41 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $5.78 Million - $6.66 Million	40,000 New	40,000 $6.37 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $8.73 Million - $11.1 Million	63,400 Added 99.84%	126,900 $19.4 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $18 Million - $22.4 Million	-136,500 Reduced 68.25%	63,500 $10.3 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $10.7 Million - $13.6 Million	100,000 Added 100.0%	200,000 $27.1 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $10.6 Million - $12.1 Million	100,000 New	100,000 $10.8 Million
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $8.89 Million - $9.79 Million	-86,900 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $2 Million - $2.7 Million	24,800 Added 39.94%	86,900 $9.31 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $1.88 Million - $2.21 Million	-21,900 Reduced 26.07%	62,100 $5.44 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $6.16 Million - $8.25 Million	84,000 New	84,000 $8.25 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $2.52 Million - $3.03 Million	-40,000 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$65.7 - $83.98 $1.64 Million - $2.1 Million	-25,000 Reduced 38.46%	40,000 $2.91 Million
Q1 2019 May 14, 2019	BUY	$77.14 - $90.79 $5.01 Million - $5.9 Million	65,000 New	65,000 $5.24 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Account